Exane Derivatives’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,154
Closed -$65.7K 692
2019
Q4
$65.7K Hold
1,154
0.01% 334
2019
Q3
$71.7K Hold
1,154
0.01% 330
2019
Q2
$82.2K Hold
1,154
0.01% 336
2019
Q1
$90.5K Buy
1,154
+734
+175% +$57.5K 0.02% 291
2018
Q4
$35.5K Buy
+420
New +$35.5K 0.01% 367